Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

Table 6

Glomerular filtration rate and serum creatinine at entry, after administration of 1 mg tesaglitazar for 6 weeks, and at followup 3 weeks after drug administration. Mean and standard deviation (in parenthesis).

	CKD patients			Healthy reference group
	At entry	After 6 weeks	After 3 weeks of drug	At entry	After 6 weeks	After 3 weeks of drug
GFR (mL/min × 1.73 m^2 BSA)	43.2 (24.0)	37.7 (21.1)	43.4 (28.3)	94.6 (13.2)	91.9 (15.5)	91.8 (10.4)
S-creatinine (µmol/L)	201 (66)	249 (93)	226 (89)	71 (11)	79 (8)	72 (10)